Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
183.6 USD | -1.56% | -3.21% | -7.99% |
Financials (USD)
Sales 2024 * | 2.72B | Sales 2025 * | 3.04B | Capitalization | 12.09B |
---|---|---|---|---|---|
Net income 2024 * | 449M | Net income 2025 * | 549M | EV / Sales 2024 * | 3.9 x |
Net cash position 2024 * | 1.46B | Net cash position 2025 * | 2.25B | EV / Sales 2025 * | 3.23 x |
P/E ratio 2024 * |
27.4
x | P/E ratio 2025 * |
21.3
x | Employees | 8,384 |
Yield 2024 * |
0.02% | Yield 2025 * |
-
| Free-Float | 84.08% |
Latest transcript on NICE Ltd.
1 day | -1.56% | ||
1 week | -3.21% | ||
1 month | -17.87% | ||
3 months | -25.12% | ||
6 months | -3.26% | ||
Current year | -7.99% |
Managers | Title | Age | Since |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 14-04-29 |
Darren Rushworth
PSD | President | 56 | 16-12-31 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 16-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 13-07-31 |
David Kostman
CHM | Chairman | 59 | 00-12-31 |
Dan Falk
BRD | Director/Board Member | 79 | 00-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.31% | 16 M€ | +2.01% | ||
0.60% | 2 M€ | +24.97% | ||
0.28% | 7 M€ | -.--% | - | |
0.16% | 20 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 183.6 | -1.56% | 777,655 |
24-05-30 | 186.5 | -2.01% | 567,656 |
24-05-29 | 190.3 | -0.53% | 311,700 |
24-05-28 | 191.3 | +0.88% | 461,819 |
24-05-24 | 189.7 | -0.23% | 389,461 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.91% | 85.92B | |
+5.14% | 77.93B | |
-16.20% | 52.89B | |
+26.18% | 48.28B | |
+28.93% | 45.38B | |
-34.05% | 40.83B | |
+66.72% | 38.78B | |
-0.36% | 27.48B | |
-26.47% | 21.52B |
- Stock Market
- Equities
- NICE Stock
- NICE Stock